Gene · 716
Papers3,534
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
761 to 780 of 3,534
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Complement-Related Gene Signature for Predicting Overall Survival and Immunotherapy Efficacy in Sarcoma Patients. | Front Cell Dev Biol | 2022 | 35493104 | PubTator, text mining | PubMed |
| Recent advances in treatments of adult immune thrombocytopenia. | Blood Res | 2022 | 35483935 | PubTator, text mining | PubMed |
| Pyroptosis-Related Signature Predicts Prognosis and Immunotherapy Efficacy in Muscle-Invasive Bladder Cancer. | Front Immunol | 2022 | 35479097 | PubTator, text mining | PubMed |
| Cell type and gene expression deconvolution with BayesPrism enables Bayesian integrative analysis across bulk and single-cell RNA sequencing in oncology. | Nat Cancer | 2022 | 35469013 | PubTator, text mining | PubMed |
| Unveiling the Bio-corona Fingerprinting of Potential Anticancer Carbon Nanotubes Coupled with D-Amino Acid Oxidase. | Mol Biotechnol | 2022 | 35467257 | PubTator, text mining | PubMed |
| Transcriptional Profiling and Deriving a Seven-Gene Signature That Discriminates Active and Latent Tuberculosis: An Integrative Bioinformatics Approach. | Genes (Basel) | 2022 | 35456421 | PubTator, text mining | PubMed |
| Squamous Cell Carcinoma in Patients with Inherited Epidermolysis Bullosa: Review of Current Literature. | Cells | 2022 | 35456044 | PubTator, text mining | PubMed |
| The effects of exercise on complement system proteins in humans: a systematic scoping review. | Exerc Immunol Rev | 2022 | 35452398 | PubTator, text mining | PubMed |
| Application of quantitative protein mass spectrometric data in the early predictive analysis of target engagement by monoclonal antibodies. | Clin Transl Sci | 2022 | 35445800 | PubTator, text mining | PubMed |
| Mitoxantrone modulates a heparan sulfate-spike complex to inhibit SARS-CoV-2 infection. | Sci Rep | 2022 | 35440680 | PubTator, text mining | PubMed |
| Subunits of C1Q Are Associated With the Progression of Intermittent Claudication to Chronic Limb-Threatening Ischemia. | Front Cardiovasc Med | 2022 | 35433866 | PubTator, text mining | PubMed |
| Can Gene Expression Analysis in Zero-Time Biopsies Predict Kidney Transplant Rejection? | Front Med (Lausanne) | 2022 | 35433772 | PubTator, text mining | PubMed |
| Innovative immunosuppression in kidney transplantation: A challenge for unmet needs. | World J Transplant | 2022 | 35433332 | PubTator, text mining | PubMed |
| Immune and endocrine responses of Cururu toads (Rhinella icterica) in their natural habitat after LPS stimulation. | Comp Biochem Physiol A Mol Integr Physiol | 2022 | 35421537 | PubTator, text mining | PubMed |
| Sutimlimab: First Approval. | Drugs | 2022 | 35412113 | PubTator, text mining | PubMed |
| Influence of 30 and 60 Min of Hypobaric Hypoxia in Simulated Altitude of 15,000 ft on Human Proteome Profile. | Int J Mol Sci | 2022 | 35409267 | PubTator, text mining | PubMed |
| Balancing the View of C1q in Transplantation: Consideration of the Beneficial and Detrimental Aspects. | Front Immunol | 2022 | 35401517 | PubTator, text mining | PubMed |
| Understanding Health Inequalities Through the Lens of Social Epigenetics. | Annu Rev Public Health | 2022 | 35380065 | PubTator, text mining | PubMed |
| The Role of the Complement System in Chronic Inflammatory Demyelinating Polyneuropathy: Implications for Complement-Targeted Therapies. | Neurotherapeutics | 2022 | 35378684 | PubTator, text mining | PubMed |
| High Stromal SFRP2 Expression in Urothelial Carcinoma Confers an Unfavorable Prognosis. | Front Oncol | 2022 | 35372028 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/716/papers?page=39